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EDITORIAL REVIEW
Targeted oncogenesis: A powerful method to derive renal
cell lines
The availability of tissue-specific cell lines which can grow
indefinitely in vitro has greatly enhanced research on biological
systems. These lines can be derived (i) from tumors arising
spontaneously or induced by mutagens or infection with viruses
expressing oncogenes, or (ii) from cells in primary culture, either
transfected with cloned oncogenes or infected with oncoviruses.
The first approach is efficient but in general poorly-specific since
many different cell types are usually proliferating in natural or
induced tumors, except when the transforming virus has a very
limited cell tropism allowing a cell type-specific transformation
(for example B lymphocyte immortalization with Epstein-Barr
virus). The simian virus 40 (SV4O), discovered in 1960 by Sweet
and Hilleman [1], has been extensively used to immortalize a
broad variety of cell types. The capacities of cellular immortaliza-
tion and transformation of SV4O are mainly due to the large T
antigen which is principally localized in the nucleus of the infected
cells and associated with known anti-oncogenes such as Rb and
p53. The little t antigen plays a minor role and only potentiates
the transforming action of the large T antigen [2—6]. The immor-
talizing properties of the simian virus large T antigen have been
used for the immortalization of a large variety of non-epithelial
and epithelial cells of different origins. Other DNA tumor viruses
(adenoviruses, papilloma viruses, etc.) have also been used.
Primary cultures of isolated cortical renal cells, tubule suspen-
sions or immunodissected cells have been successfully trans-
formed by infection with SV4O or with adenovirus 12-SV4O hybrid
or by transfection with SV4O early region DNA [7—9]. These
different cell lines have conserved most the the features of
parental cells. However, in our experience, the SV4O-transformed
renal cells tends to loose their cell-specific functions after long-
term passages. Therefore, the usefulness of SV4O-transformed
cell lines may be limited because of characteristics introduced by
the transforming process in vitro [10, 11]. Furthermore, Handlog-
ten et al [12] showed that infection with SV4O lead to the
maintenance of rat fetal hepatocytes in proliferative state which
impaired further differentiation. To circomvence such problems
and to analyze the specific role of large T antigen on specialized
functions, several groups [13—15] have used a temperature-sensi-
tive mutant of SV4O which can be activated at a permissive
temperature (33°C to 35°C) or repressed at a restrictive temper-
ature (39.5°C). Concerning kidney cells, Prié et al [16] have
transformed a rabbit kidney cell line exhibiting features of prin-
cipal collecting tubule cells with the temperature-sensitive TsA58
mutant and showed that the activation of SV4O at permissive
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temperature effectively repressed AMP cyclic response to arginin
vasopressin, acting normally on this particular cell type. Transfec-
tion is limited by its low efficiency that reduces the chance of
deriving clones of interest, and despite its efficiency, infection of
primary cultures does not allow the transformation of cells that
are very rare in vivo. Thus, the only available alternative was until
recently to work with uncloned cells in primary cultures which
kept their differentiated function during a very short period, or
with a few clonal and often poorly-differentiated immortalized cell
lines. Recently this situation has been considerably improved by
the development of the targeted oncogenesis strategy in trans-
genic mice, affording a completely new approach to the derivation
of cell lines harboring both differentiated and immortalized
features.
Targeted oncogenesis in transgenic animals
The introduction of genes into the germ line of mammals can
be considered as a major technological advance in biology [17].
Transgenic animals have indeed provided new insights into the
mechanisms of development, gene regulation, study of the im-
mune system, not to mention exciting possibilities for producing
proteins or generating animal models for human diseases. A
number of valuable models for cancers have thus been created in
mice by targeted oncogenesis [18—20]. In this approach, a trans-
gene consisting of a cell-type specific regulatory sequence linked
to an oncogene is microinjected into the pronucleus of fertilized
mouse eggs. Their development gives rise to transgenic mice
carrying the transgene in all of their cells but expressing it only in
the cell type in which the chosen regulatory sequences are active.
For example, transgenic mice carrying the reniTSV4O transgene,
in which the simian virus 40 (SV 40) early genes are under the
control of the regulatory sequences of the renin gene, will express
the transgene only in the renin-expressing cells [21]. Primary
cultures of renal cells from these animals indicate that only those
cells able to transcribe the renin gene will express the oncogene
and, therefore, will be able to proliferate [22].
As a consequence of this strategy, the endogeneous differenti-
ated genes whose activation requires the same regulatory factors
as those necessary for the transgene expression will remain active,
and thus differentiated function will be positively selected, at least
when cells are isolated from precancerous tissues. In addition, the
fact that the oncogene is expressed in every cell of the primary
culture derived from transgenic animals, that cell lines can be
established at any moment during the oncogene-dependent trans-
formation process and that rare cell types, even when dispersed in
a complex tissue organisation, can be expanded, make derivation
of immortalized cell lines from transgenic mice a very efficient and
versatile method.
A variety of interesting epithelial and non-epithelial cell lines
388
Briand et al: Tissue-specific cell lines 389
have already been derived from transgenic mice expressing onco-
genes [reviewed 23, 24]. Some of them correspond to cell types
that have never been described before, whereas others have
retained more differentiated functions than previously trans-
formed lines of the same cell type and, in general, their phenotype
is stable over many passages in culture.
Establishment and properties of some renal cell lines derived
from transgenic mice
The architectural complexity and the cellular heterogeneity of
the kidney have made it particularly difficult to isolate pure
population of specific cell types. Even the best characterized
mammalian renal cell lines such as the LLC-PK1 [25, 26], MDCK
[271 or OK [28] lines are of unclear origin [29] and do not allow
a precise association between the observed cellular functions and
a particular cell type in vivo. Thus, many studies have required the
use of primary cell cultures with all limitations of this approach.
More recently, infection or transfection of primary cultures of
cortical cells and isolated tubules from rabbit kidney suspensions
by either wild type strain of SV4O [7, 30, 31], thermosensitive
mutant of 5V40 [16], or adenovirusl2-SV4O hybrid [9] have
nevertheless allowed establishment of various tubular epithelial
cell lines which have maintained the principal features of proximal
tubule, thick ascending limb or cortical collecting tubule cells.
Avoiding in vitro infection or transfection of primary or subcul-
tured cells, targeted oncogenesis would appear an alternative
approach with extended potentialities. Table 1 summarizes the
renal cell lines which have been derived to date from transgenic
animals. Even though they are not yet representative of the renal
cell type diversity, they already constitute a panel of very inter-
esting models, rendering optimistic the prospects for future
development.
Glomerular cell lines
MacKay et al [32] were the first to report the establishment of
immortalized glomerular cell lines from glomerular cell suspen-
sions of kidneys from C57B116J X SJL/J mice transgenic for the
early region of SV4O [33, 34]. Several clones of glomerular cell
lines were obtained using a cloning ring strategy. The cellular
types were characterized by using several methods: indirect
immunofluorescence studies, contractility upon angiotensin II
addition, and activity of two enzymes (alkaline phosphatase and
gamma-glutamyl transpeptidase; Table 1). The glomerular epithe-
hal (GEp) cells were characterized by the presence of cytokeratin,
failure to contract in the presence of angiotensin II and a negative
staining for factor VIII related antigen. The glomerular mesangial
(GM) cells were shaped like elongated spindle and were able to
contract in response to angiotensin II. They were actin-positive,
cytokeratin- and factor VIlI-related antigen-negative, while the
glomerular endothelial (GEn) cells exhibited a positive staining
for factor Vill-related antigen. All of these cells were clonal and
homogenous. They maintain features of their normal counterpart,
and thus, despite their transformed phenotype, may be valuable
for studies of glomerular cell biology.
Cortical collecting duct cell lines
More recently, a cortical collecting duct (CCD) cell line has
been derived from transgenic mice harboring the early region of
SV4O, Tg(SV4OE)Bri7 [33]. This cell line, referred to as M-1, was
Transgene Renal Name
(Re Se/ cell of the
Cod Se) type cells Characteristics References
GEp GEp Cobblestone morphology
Cytokeratin + Factor
VIII related Ag —
GGT and AP -
GEn GEn Smaller than GEp
Cytokeratio — Factor
VIII related Ag
GM GM Elongated cells
Cytokeratin — Factor
VIII related Ag —
Angiotensin IT
induced contractility
CCD M-1 Polarized cuboid cells
High transepithelial
electrical resistance
AVP stimulation of
cAMP Cortical
collecting duct
antigens positivity
Flat cells forming domes
at confluence
Dendritic cytoplasmic
processes, Take up of
acetylated LDL, AVP
stimulation of cAMP
JG TC-1 to Prorenin secreting cells
TC-5
PT PKSV- Polarized cuboid cells
PR PCT with apical microvilli;
PKSV- Dome formation; Low
PR transepithelial
resistance and small
apical negative
voltage. PTH and CT
stimulation of cAMP;
Hydrolases +; Villin
+ in apical brush
border;
Aminopeptidase N,
PK, PEPCK and
GGT +
PT PKmycP Cystic cells
CT
Abbreviations are: Re Se/Cod Sc, regulatory sequence/coding sequence;
PT, proximal tubule; PR, pars recta; JG, juxtaglomerular; DT, distal
tubule; E, endothelial; CCD, cortical collecting duct; GEp, glomerular
epithelial; GEn, glomerular endothelial; GM, glomerular mesangial;
GGT, gamma glutamyl transpeptidase; AP, alkaline phosphatase; PK,
pyruvate kinase; PEPCK, phosphoenolpyruvate carboxykinase.
derived from microdissected cortical light collecting tubules.
These M-1 cells maintain the major features of the parental CCD
cells and exhibit a high transepithehial resistance when grown on
permeable filters [35]. They are also sensitive to arginine vaso-
pressin, known to act on CCD tubules [36]. Using cell lines cloned
from M-1 cells, Fejes-Toth and Naray-Fejes-Toth [37] have
showed that they exhibit both principal (PC) and intercalated
(ICC) cell functions with mutually exclusive heterogenous expres-
sion of PC and ICC antigens, demonstrating a common origin of
the two cell types. Furthermore, Stoos, Carretero and Garvin [38]
have used M-1 cells to study the interactions of atrial natriuretic
Table 1. Characteristics of the renal cell lines derived from transgenic
mice
SV4O/T
SV4O
5V40/T
5V40
SV4O1Tts DT TKC2
5V40
En TKD2
[34]
[35]
[44]
[22]
[42, 43]
Vandewalle et al
(personal
communication)
Ren/T
5V40
PK-L/T
5V40
PK-L/c-
myc
W•L.,, ,-, E
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Fig. 1. Morphology of confluent PKSJ/-PCT cells grown on plastic petri dishes and permeable filters. A. Confluent PKSV-PCT grown on collagen-coated
petri dishes form numerous domes. B. Grown on filters, cells are organized as monolayer of polarized cuboid cells separated by tight junctions and
desmosomes. Note the presence of numerous apical microvilli. C. Illustration of brush border microvilli from proximal cells labeled with a monoclonal
antibody directed against aminopeptidase-N (APN) (see Cattier et al [42]). D, E. Apical localization of APN illustrated by confocal laser scanning
microscopy (D, x-y plane; e, x-z plane). Note the regular and intense labeling restricted to the apical side of cells. Bars are: A, 50;tm; B,C, 2 jim; D,
E, 10 m.
factor and bradykinin on ionic transport. Thus, M-1 cells appear
to represent a very attractive model of immortalized CCD cells for
the study of ion transport regulation and of the effects of different
hormones, such as corticosteroids, which specifically act on CCD
cells.
Proximal tubule cell lines
We have also established two proximal tubule cell lines derived
from the kidney of L-PKIFag-1 transgenic mice [391. These cell
lines (PKSV-PCT and PKS V-PR) were derived from early (PCT)
and late (Pars Recta, PR) microdissected proximal tubules. Cells
were cultured in a D-glucose-enriched medium, permitting the
activation of the L-pyruvate kinase promoter [40, 41]. In such
culture conditions, both cell lines stably expressed SV4O-encoded
nuclear large T antigen. Grown on plastic supports or porous
filters, they were organized as cell monolayers with well-devel-
oped apical microvilli, and they formed domes. Both cell lines
exhibited the morphological features of proximal tubule (PT) cells
with villin located in the apical brush and substantial amounts of
hydrolase activity. Immunofluorescence studies using specific
antibodies, showed that the amino peptidase N (APN) appeared
restricted to the apical microvillar domain, whereas the H2
histocompatibility antigen was distributed in the cytoplasm and
lateral membranes [42]. Figure 1 summarizes the morphology of
the cells grown on plastic supports or permeable filters and the
apical localization of APN. PKSV-PCT and PKSV-PR cells were
parathormone (PTH) and calcitonin (CT) cyclic AMP inducible,
had a sodium-dependent glucose transporter and exhibited signif-
icant apical and basolateral endocytic capacities [43]. In both
transgenic cell lines, the expression of the T antigen (Tag)
remained dependent on the concentration of D-glucose in the
medium, indicating that the L-PK construct retains its capacity to
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be regulated by carbohydrates [43]. Replacement of D-glucose by
neoglucogenic substrates (lactate, oxaloacetate) drastically re-
duced the expression of Tag transcripts and resulted in the arrest
of cell growth [43]. Under these conditions, where Tag is inacti-
vated, the proximal functions were nevertheless preserved. Thus,
these transgenic PKSV-PCT and PKSV-PR cell lines allow com-
parative studies of proximal function in quiescent and active
growth conditions and represent an alternative model to other
established proximal cell lines such as OK or LLC-PK1 cells [25,
26, 28]. Their high level of differentiation compared to the renal
cell lines previously obtained by infection of primary cell culture
with SV4O may be related to their low oncogenic potential
attested by the fact that they failed to provoke tumors after
transfer into athymic mice. The ability to modulate transgene
expression by changing the culture conditions could allow just
enough proliferative activity to extend the population while
interfering to a minimum with the specific cellular function. The
use of a temperature-sensitive mutant of SV4O (SV4OA58) could
be also of interest for a similar purpose since this mutant can be
activated at 33°C (permissive temperature) or inhibited at 39,5°C
(restrictive temperature) [13, 16]. Yanai et al [441 have established
tubule cell lines from transgenic mice harboring the temperature-
sensitive SV4O large T antigen gene. One of them, (TKC2)
referred as distal tubule cells, show temperature-sensitive growth
in culture, form domes and were sensitive to arginine vasopressin
at permissive temperature. However TKC2 cells did not respond
to AVP at restrictive temperature (39.5°C) a result that disagrees
with the reported AVP receptor modifications in the principal
cortical collecting duct cell types established by in vitro transfor-
mation of rabbit epithelial renal cell lines with the temperature-
sensitive SV4OSA 5 8 [16]. Several speculative hypothesis could be
advanced to explain these discrepancies: it can be argued that in
the two studies, not only the species were different but also the
levels of SV4O-expression and the culture conditions. In addition,
phenotypic alterations due to insertional mutagenesis cannot be
excluded. Conclusive interpretations clearly need further studies.
Renal cell lines able to form cyst
Another purpose could be to obtain models of abnormal renal
cells with the aim of studying their characteristics. Trudel, D'Agati
and Costantini [451 have described a line of transgenic mouse
harboring the murine c-myc gene driven, by the SV4O enhancer
and the adult 3-globin promoter, that bears many similarities with
the human autosomal-dominant polycystic kidney disease. It
appears that, in this model, cyst formation could result from an
overexpression of c-myc in the renal tubular epithelium and
consequent cell proliferation. We also observed that the kidneys
of L-PK/c-myc transgenic mice fed with a carbohydrate-rich diet
(a condition for activation of the L-PK promoter, and thus for
c-myc expression) presented microcyst formations restricted to
the proximal convoluted tubule. This led us to establish a cell line
from the proximal tubule of the L-PK!c-myc transgenic mice in
order to study in vitro the phenotype of proximal cells having the
capacity to form cysts. Preliminary results indicate that it is
possible to reconstitute renal cysts with such a cell model cultured
in collagen matrix.
Conclusion and perspectives
As can be deduced from an analysis of Table 1, many renal cell
types remain to be established, particularly from the distal seg-
ments (that is, thick ascending limb cells, distal bright cells, distal
convoluted cells, medullary collecting tubule cells). Their estab-
lishment will require the use of specific regulatory sequences able
to target expression of a chosen oncogene in the corresponding
cells of transgenic animals. In Table 2 the regulatory sequences
that have already been shown to drive expression of a transgene in
the kidney. Linked to sequences encoding an oncogene, they
might be used in targeted oncogenesis experiments. The expres-
sion controlled by some of them (MT, PEPCK, PK-L, MMTV)
can be modulated ex vivo and in vivo which further enhances the
potential of this method. One of the main advantages of the
targeted oncogenesis method derives from the possible associa-
tion between any regulatory sequence and any oncogene. DNA
consensus boxes can also be associated to constitute new types of
regulatory sequences whose function will require the presence of
specific transcription factors that will activate both the expression
of the transgene and the expression of a group of specific genes.
Even though we cannot expect that the transformed cell will keep
all the characteristics of the parental one, we have thus the
possibility to derive cells in which some of the important meta-
bolic pathway are preserved because the transcriptional factors
controling the corresponding genes are identical to those that
control the oncogene expression. In a way, this method induces at
least transiently, a positive selection in favor on two frequently
antinomic properties: transformation and differentiation. As ex-
amples, Antoine et al [461 and Effrat, Surana and Fleischer [47]
have clearly shown that cell lines derived from hepatic and
n-pancreatic tumors of transgenic animals, respectively, remained
differentiated in culture. Consequently, the fact that infection of
cells by SV4O does not frequently allow the production of
differentiated cells cannot be considered as the direct effect of the
oncogene. It more probably relies on the in vitro selection
accompanying the early culture phase than to causal events of the
immortalization. Using targeted oncogenesis avoids the step of in
vitro selection and allows insertion in cultured cells that already
have proliferative potential but have still enough differentiated
functions to play their normal role in the organism. Another
feature of targeted oncogenesis that enhance the chance to derive
differentiated cell lines derives from the ability to choose the
moment at which the culture will be made. The age of the animals
seems to be a critical step for establishing the cell lines. In our
experience, the PKSV-PCT and PKSV-PR proximal tubule cell
lines have been derived from young animals at a stage were no
histological lesions were detected. Analyses of the kidneys from
older LPKJTag1 transgenic mice fed continuously with an en-
riched carbohydrate diet, showed the presence of histological
lesions inconstantly represented by cyst formations resembling to
those observed in the kidney of transgenic mice carrying the
constitutive SV4O [34]. As in the previously-mentioned study, the
cell lines derived from these elderly animals would have been
probably more interesting for the analysis of cyst formation than
for their differentiated functions. That means that a same trans-
genic model might allow the establishment of a number of
interesting cell lines from one cell type depending on the differ-
entiation state at which the parental cells are put in culture.
Finally, as for primary culture, the conditions of culture are also
critical for the maintenance of the phenotype. This is particularly
true for proximal cells which possess high neoglucogenic capaci-
ties. Previous studies have shown that enhanced glycolytic capac-
ities associated with a decline of oxydative metabolism occurred in
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Table 2. Examples of regulatory sequences that reproducibly drive
expression in the kidney of transgenic mice when associated with
various coding sequences
Transgenes
Regulatory Coding Expression
sequences sequences in the kidney
MT RcLDL Proximal and distal
tubules
Vasopressin Positive (ND)
OH Proximal convoluted
tubules
Positive (ND)
Positive (ND)
Positive (ND)
Epithelial cells of
Bowman's capsule
and tubules
EPO Peritubular
interstitial cells
Proximal tubule
Positive (ND)
Positive (ND)
Positive (ND)
Positive (ND)
Positive (ND)
Positive (ND)
Low and variable
(ND)
Positive (ND)
Positive (ND)
Duct-derived
epithelium of the
meso- and meta-
nephric kidney and
associated duct
cells
Positive (ND)
Positive (ND)
Positive (ND)
Positive (ND)
Positive (ND)
Proximal tubules
Positive (ND)
Positive (ND)
Juxtaglomerular cells
(in neonates);
vascular cells (in
adults)
Tubular epithelial
cells
Epitheliod
juxtaglomerular
cells
Abbreviations are: NGF, nerve growth factor; Ren, renin; GH, growth
hormone; HBV, hepatitis B virus; MSV, mouse sarcoma virus; CMV,
cytomegalo virus; AAT, alpha 1 antitrypsine; MT, metallothionein; MHC,
major histocompatibility complex; EPO, erythropoietin; Apo E, apoli-
poprotein E; MDR, multi-drug resistance; NF L, neurofilament L; CAT,
chloramphenicol acetyl transferase (E. coli); PK-L, pyruvate kinase L;
PEPCK, phospho-enol-pyruvate-carboxy-kinase; ND, expression in the
kidney which has not been precisely located.
primary cultures of proximal renal cells [48, 49]. This is also the
case for the PKSV-PCT and PKSV-PR proximal cells that we
have established. However, these cells maintained a low expres-
of transgenesis in other species than mice and particularly in rats
should be of particular interest since a large amount of physio-
logical and pharmalogical studies have been performed on this
species. Transgenic rats, rabbits, pigs, etc., have already been
obtained, but at the moment derived cell lines have not been
reported.
Finally, the number of new cell lines that will be obtained by
targeted oncogenesis will surely constitute valuable models for the
evaluation of drug nephrotoxicity and pharmacology, with ethical
issue to reduce the need for in vivo experimentations.
PASCALE BRIAND, AXEL KAHN, and ALAIN VANDEWALLE
Paris, France
Acknowledgments
This work was supported by the INSERM and grants from the
Association pour Ia Recherche sur le Cancer (n° 6744, 6797) and the Ligue
Nationale Contre le Cancer. We thank F. Cluzeaud (INSERM U246) for
morphological and immunocytochemical illustrations. We also thank R.
Hellio (Unite de Biologie des Membranes, Institut Pasteur, Paris) for
providing the image generated by confocal laser scanning microscopy.
Reprint requests to Dr. P. Briand, INSERM U 380, Institut Cochin de
Genetique Moléculaire, 22 rue Méchain, 75014 Paris, France.
References
1. SwEET BH, HILLEMAN MR: The vacuolating virus, S.V.40. Proc Soc
Exp Biol Med 105:420—427, 1960
MT
MT
MT
MT
Angiotensinogen
Poliovirus Re
EPO
PEPCK
PEPCK
ApoE
MHC class I
Angiotensinogen
Poliovirus Re
sion of the phosphoenolpyruvate carboxykinase, a neoglucogenic
key enzyme, which remain stimulated by cAMP.
Finally the possibility to chose any cloned oncogene is another
element of flexibility and power of the targeted oncogenesis
approach. Generally speaking, apart from their more or less
proliferative, immortalizing and transforming activities, onco-
genes are not likely to directly disrupt the same differentiated
functions. Consequently, transgenic mice expressing different
oncogenes might allow the establishment of cells that will retain
different functions. The specific effects on the kidney of ras, myc
and more recently erbB-2 gene expression are being studied in
transgenic mice and will give the opportunity to derive more or
less differentiated renal cell lines. It is important to keep in mind
that cells that retain all the functions of their in vivo counterparts
are not likely to be obtained, but the power of the approach lies
in the possibility of deriving a number of models, each of them
keeping active one or another of its specific activity. Once
characterized, one of the main possibilities offered by such cell
lines, will be their use in the analysis of drug nephrotoxicity. Such
a work has been initiated by one of us (Riccaldi et al, manuscript
in preparation) who studied the mechanism by which aminosides
(gentamycin, amikacin) stimulate exocytosis of lysosomal enzymes
in the model of PKSV-proximal cells described above.
In this review, we outline the principle reasons why targeted
oncogenesis has already opened exciting new possibilities in the
field of differentiated renal cell culture, and is likely to continue to
do so. The use of new promoters associated with various onco-
genes will raise the possibility to derive new renal cell lines. Those
derived from epithelial cells of the more distal segments of the
renal tubule will be of particular interest. All of them should
represent useful tools for a number of physiological studies and
the analysis of pathological processes. Moreover, the development
References
[50]
[51]
[52]
[53]
[54]
[55]
[56]
[57]
[58—60]
[61]
[62]
[63, 64]
[65]
[66]
[40]
[39]
[67]
[68, 69]
[70]
[71]
[72]
[731
[741
[751
[76—80]
[81]
[82]
[83]
[84, 85]
[86]
[87]
PEPCK
Growth
hormone
E. coli ada
AAT
CAT or T SV4O
T SV4O
CAT
SV4O early
region
aB cristallin
ApoE
MDR
LacZ
Keratin 18
NF L
BK early region
CMV
HBV
rasT24
GH
Ren 2
T SV4O
erbB2
Ren
AAT
AAT
AAT
PK-L
PK-L
aB cristallin
ApoE
MDR
Hox2-3
Keratin 18
MSV
BK
CMV
HBV
yGT
NGF
Ren 2 (mouse)
Ren
MMTV
Ren (human)
Briand et al: Tissue-specific cell lines 393
2. LIVINGSTON D, BRADLEY P: The simian virus 40 large T antigen: A lot
packet into a little. Mol Biol Med 4:63—80, 1987
3. FANNING E, KNIPPERS R: Structure and function of simian virus 40
large tumor antigen. Ann Rev Biochem 61:55—85, 1992
4. RUBIN H, FIGGE J, BLADON M, CHEN LB, ELLMAN M, BnmL I, FARELL
M, LIVINGSTON D: Role of small t antigen in the acute transforming
activity of SV4O. Cell 30:469—480, 1982
5. BIxEL I, MONTANO X, AGHA M, BROWN M, MCCORMACK M, BOLL-
TAX J, LINVINGSTON D: SV4O small t antigen enhances the transfor-
mation activity of limiting concentrations of SV4O large T antigen. Cell
48:321—330, 1987
6. CI-ioi YW, LEE IC, Ross SR: Requirement for the simian virus 40
small tumor antigen in tumorigenesis in transgenic mice. Mol Cell Biol
8:3382—3390, 1988
7. Scorr D, MACDONALD C, BEZESKI H, KINNE R: Maintenance and
expression of differentiated function of kidney cells following trans-
formation by SV4O early region DNA. Exp Cell Res 166:391—398, 1986
8. VANDEWALLE A, LELONGT A, GENITEAU-LEGENDRE M, BAUDOIN B,
ANTOINE M, ESTRADE S, CHATELET F, VERROUST P, CASSINGENA R,
RoNco P: Maintenance of proximal and distal cell functions in
SV4O-transformed tubular cell lines derived from rabbit kidney cortex.
J Cell Physiol 141:203—221, 1989
9. AREND L, HANDLER J, RHIM J, Gu50vSKI F, SPIELMAN W: Adenosine-
sensitive phosphoinositide turnover in a newly established renal cell
line. Am J Physiol 256:F1067—F 1074, 1989
10. CHERINGTON V, MoRGAN B, SPEIGELMAN M, ROBERTS T: Recombi-
nant retroviruses that transduce individual polyoma tumor antigens:
Effects on growth and differentiation. Proc NatI Acad Sci USA
83:4307—4311, 1986
11. AMSTERDAM A, ZAUBERMAN A, MEIR G, PINHASI-KIM}1I B, SuH BS,
OREN M: Cotransfection of granulosa cells with simian virus 40 and
Ha-Ras oncogen generates stable lines capable of induced steroido-
genesis. Proc Natl Acad Sci USA 85:7582—7586, 1988
12. HANDLOGTEN ME, KILBERG MS: Growth-dependent regulation of
system A in SV4O-transformed fetal rat hepatocytes. Am J Physiol
(Cell Physiol 24) 255:C261—C270, 1988
13. Cnou JY: Establishment of rat fetal liver lines and characterization of
their metabolic and hormonal properties: Use of temperature sensi-
tive SV4O virus. Meth Enzymol 109:385—396, 1985
14. IsoM HC, TEVETHIA Mi, TAYLOR JM: Transformation of isolated rat
hepatocytes with simian virus 40. J Cell Biol 85:651—659, 1980
15. BANKS-SCHEGEL SP, HOWLEY PM: Differentiation of human epider-
mal cells transformed by SV4O, J Cell Biol 96:330—333, 1991
16. PRIE D, RONCO M, BAUDOIN B, GENITEAU-LEGENDRE M, ANTOINE M,
PIEDAGNEL R, ESTRADE S, LELONGT B, VERROUST P, CASSINGENA R,
VANDEWALLE A: Activation of the simian virus 40 (SV4O) genome
abrogates sensitivity to AVP in a rabbit collecting tubule cell line by
repressing membrane expression of AVP receptors. J Cell Biol 113:
951—962, 1991
17. GROSVELD F, KOLLAIS G: Transgenic animals. London, Academic
Press, 1992
18. HANAIL&N D: Transgenic mice as probes into complex systems. Science
246:1265—1275, 1989
19. HANAA.N D: Dissecting multistep tumorigenesis in transgenic mice.
Anna Rev Genet 22:479—519, 1988
20. COMPERE SJ, BALDACCI P, JAENISCH R: Oncogenes in transgenic mice.
Biochim Biophys Acta 948:129—149, 1988
21. FUKAMIZU A, HATAE T, KON Y, SUGIMURA M, HASEGAWA T,
YOKOYAMA M, NOMURA T, KATSUKI M, MURAKAMI K: Human renin
in transgenic mouse kidney is localized to juxtaglomerular cells.
Biochem J 278:601—603, 1991
22. SIGMUND CD, OKUYAMA K, INGELFINGER J, JONES CA, MULLINS JJ,
KANE C, KIM U, Wu CZ, KENNY L, RUSTUM Y, DZAU Vi, GROSS KW:
Isolation and characterization of renin-expressing cell lines from
transgenic mice containing a renin-promoter viral oncogene fusion
construct, J Biol Chem 265:19916—19922, 1990
23. KAHN A, BRIAND F: Etablissement de lignees cellulaires par onco-
genèse ciblée. mis 7:IV—IX, 1991
24. KIOUSSIS D: Oncogenesis in transgenic mice, in Transgenic Mice,
edited by F GROSVELD, G KOLLIAS, London, Academic Press, 1992
25. MISFELOT D, SANDERS M: Transepithelial transport in cell culture: D
glucose transport by a pig kidney cell line (LLC-PK1). J Membr Biol
22:13—18, 1981
26. RABITO C, AUSIELLO D: Na-dependent sugar transport in cultured
epithelial cell line from pig kidney. J Membr Biol 54:31—38, 1980
27. GAUSH C, HARD W, SMITH T: Characterization of an established line
of canine kidney cells (MDCK). Proc Soc Exp Biol Med 122:931—935,
1966
28. CAVERZASIO J, Rzzou R, BONJOUR J: Sodium-dependent phosphate
transport inhibited by parathyroid hormone and cyclic AMP stimula-
tion in an opposum kidney cell line. J Biol Chem 261:3233—3237, 1986
29. GSTRAUNTFIALER G, PFALLER W, KOTENTO F: Biochemical character-
ization of renal epithelial cell cultures (LLC-PK1 and MDCK). Am J
Physiol 248:F536—F544, 1985
30. ROMERO M, DOUGLAS J, ECKERT R, HOPPER U, JACOBBERGER J:
Development and characterization of rabbit proximal tubular epithe-
hal cell lines. Kidney mt 42:1130—1144, 1992
31. VANDEWALLE A, LELONGT B, GENITEAU-LEGENDRE M, BAUDOUIN B,
ANTOINE M, ESTRADE 5, CHATELET F, VERROUST P, CASSINGENA R,
RoNco P: Maintenance of proximal and distal cell functions in
SV4O-transformed tubular cell lines derived from rabbit kidney cortex.
J Cell Physiol 141:203—221, 1987
32. MACKAY K, STRIKER Ii, ELLIOT 5, PINKERT CA, BRINSTER RL,
STRIKER GE: Glomerular epithelial, mesangial, and endothelial cell
lines from transgenic mice. Kidney mt 33:677—684, 1988
33. PALMITER RD, CHEN HY, MESSING A, BRINSTER RL: SV4O enhancer
and large T antigen are instrumental in development of choroid plexus
tumors in transgenic mice. Nature 316:457—460, 1985
34. MACKAY K, STRIKER LI, PINKERT CA, BRINSTER RL, STRIKER GE:
Glomeruloscierosis and renal cysts in mice transgenic for the early
region of SV4O. Kidney mt 32:827—837, 1987
35. Sroos BA, NitY FTA, CARRETERO OA, ITO S, FEJES TG: Charac-
terization of a mouse cortical collecting duct cell line. Kidney mt
39:1168—1175, 1991
36. MOREL F: Sites of hormone action in mammalian nephron. Am J
Physiol 240:F159—F164, 1981
37. FEJES-TOTH 0, NARAY-FEJES-TOTH A: Differentiation of renal b-
intercalated cells to a-intercalated and principal cells in culture. Proc
Nati Acad Sci USA 89:5487—549 1, 1992
38. STOOS B, CARRETERO 0, GARVIN J: ANF and bradykinin synergisti-
cally inhibit transport in M-1 cortical collecting duct cell line. Am J
Physiol 263:F1—F6, 1992
39. CARTIER N, MIQUEROL L, TULLIEZ M, LEPETIT N, LEVRAT F, GR1M-
BER G, BRIAND P, KAHN A: Diet-dependent carcinogensis of pancre-
atic islets and liver in transgenic mice expressing oncogenes under the
control of the L-type pyruvate kinase gene promoter. Oncogene
7:1413—1422, 1992
40. TREMP GL, BOQUET D, RIP0CHE MA, COGNET M, LONE YC, JAMI J,
KAHN A, DAEGELEN D: Expression of the rat L-type pyruvate kinase
gene from its dual erythroid- and liver-specific promoter in transgenic
mice. J Biol Chem 264:19904—19910, 1989
41. VAULONT S, MUNNICH A, DECAUX J, KAHN A: Transcriptional and
post-transcriptional regulation of the L-type pyruvate kinase gene
expression in rat liver. J Biol Chem 26 1:7621—7625, 1986
42. CARTIER N, LACAVE R, VALLET V, HAGEGE J, HELLIO R, ROBINE 5,
PRINGAULT E, CLUZEAUD F, BRIAND F, KAHN A, VANDEWALLE A:
Establishment of renal proximal tubule cell lines by targeted onco-
genesis in transgenic mice using the L-pyruvate kinase-5V40 (T)
antigen hybrid gene. J Cell Sci 104:695—704, 1993
43. LACAVE R, BENS M, CARTIER N, VALLET V, ROBINE S, PRINGAULT E,
KAHN A, VANDEWALLE A: Functional properties of proximal tubule
cell lines derived from transgenic mice harboring L-pyruvate kinase-
SV4O (T) antigen hybrid gene. J Cell Sci 104:705—712, 1993
44. Y.NAI N, SATOH T, KY0 5, ABE K, SUZUKI M, OBINATA M: A tubule
cell line established from transgenic mice harboring temperature-
sensitive simian virus 40 large T-antigen gene. Jpn J Cancer Res
82:1344—1348, 1991
45. TRUDEL M, D'AGATI V, COSTANTINI F: C-myc as an inducer of
polycystic kidney disease in transgenic mice. Kidney mt 39:665—671,
1991
46. ANTOINE B, LEVEAT F, VALLET V, BERBAR T, CARTIER N, DUB0IS N,
BRIAND F, KAHN A: Gene expression in hepatocyte-like cell lines
established by targeted carcinogenesis in transgenic mice. Exp Cell Res
200:175—185, 1992
47. EFRAT 5, SURANA M, FLEISCHER N: Glucose induces insulin gene
394 Briand et al: Tissue-specific cell lines
transcription in a murine pancreatic f3-cell line. J Biol Chem 266:
11141—11152, 1991
48. DICKMAN KG, MANuEL L: Glycolytic and oxydative metabolism in
primary renal proximal tubule cultures. Am J Physiol (Cell Physiol 26)
257:C333—C334, 1989
49. TANG MJ, KEEPLANDAL R, TANNEN RL: Carbohydrate metabolism by
primary cultures of rabbit proximal tubules. Am JPhysiol (Cell Physiol
25) 256:C532—C539, 1989
50. PATHAK RK, YOKODE M, HAMMER RE, H0FMANN SL, BROWN MS,
GOLDSTEIN JL, ANDERSON RG: Tissue-specific sorting of the human
LDL receptor in polarized epithelia of transgenic mice. J Cell Biol
111:347—359, 1990
51. HABENER JF, CWIKEL BJ, HERMANN H, HAMMER RE, PALMITER RD,
BRINSTER RL: Metallothionein-vasopressin fusion gene expression in
transgenic mice. Nephrogenic diabetes insipidus and brain transcripts
localized to magnocellular neurons. J Biol Chem 264:18844—18852,
1989
52. BRAR AK, BRINSTER RL, FROHMAN LA: Immunohistochemical anal-
ysis of human growth hormone-releasing hormone gene expression in
transgenic mice. Endocrinology 125:801—809, 1989
53. SHIMANO H, YAMADA N, SHIMADA M, OHSAWA N, FUKAZAWA C,
YAZAKI Y, TAKAKU F, KATSUKI M: Hepatic and renal expression of
rat apolipoprotein E under control of the metallothionein promoter in
transgenic mice. Biochim Biophys Acta 1090:91—94, 1991
54. MORAHAN G, BRENNAN FE, BI-IATHAL PS, ALLISON J, Cox KU,
MILLER JF: Expression in transgenic mice of class I histocompatibility
antigens controlled by the metallothionein promoter. Proc Nati Acad
Sci USA 86:3782—3786, 1989
55. KIMURA 5, MULLINS JJ, BUNNEMANN B, METZGER R, HILGENFELDT U,
ZIMMERMANN F, JACOB H, FUXE K, GANTEN D, KALING M: High
blood pressure in transgenic mice carrying the rat angiotensinogen
gene. Embo J 11:821—827, 1992
56. REN R, RACANIELLO VR: Human poliovirus receptor gene expression
and poliovirus tissue tropism in transgenic mice. J J/irol 66:296—304,
1992
57. SEMENZA GL, KOURY ST, NEJFELT MK, GEARHART JD, ANTONARA-
KIS SE: Cell-type-specific and hypoxia-inducible expression of the
human erythropoietin gene in transgenic mice. Proc NatI Acad Sci
USA 88:8725—8729, 1991
58. BEALE EG, CLOUTHIER DE, HAMMER RE: Cell-specific expression of
cytosolic phosphoenolpyruvate carboxykinase in transgenic mice.
FASEB J 6:3330—3337, 1992
59. SHORT MK, CLOUTHIER DE, SCHAEFER IM, HAMMER RE, MAGNUSON
MA, BEALE EG: Tissue-specific, developmental, hormonal, and di-
etary regulation of rat phosphoenolpyruvate carboxykinase-human
growth hormone fusion genes in transgenic mice. Mol Cell Biol
12:1007—1020, 1992
60. EISENBERGER CL, NECHUSHTAN H, COHEN H, SITANI M, RESHEF L:
Differential regulation of the rat phosphoenolpyruvate carboxykinase
gene expression in several tissues of transgenic mice. Mol Cell Biol
12:1396—1403, 1992
61. MCGRANE MM, YUN JS, MOORMAN AF, LAMERS WH, HENDRICK
GK, ARAFAH BM, PARK EA, WAGNER TE, HANSON RW: Metabolic
effects of developmental, tissue-, and cell-specific expression of a
chimeric phosphoenolpyruvate carboxykinase (GTP)Ibovine growth
hormone gene in transgenic mice. JBiol Chem 265:22371—22379, 1990
62. LIM 1K, DUMENCO LL, YUN J, DONOVAN C, WARMAN B, GORODETZ-
KAYA N, WAGNER TE, CLAPP DW, HANSON RW, GERSON SL: High
level, regulated expression of the chimeric P-enolpyruvate carboxyki-
nase (GTP)-bacterial 06-alkylguanine-DNA alkyltransferase (ada)
gene in transgenic mice. Cancer Res 50:1701—1708, 1990
63. KOOPMAN P, POVEY 5, L0VELL BR: Widespread expression of human
alpha 1-antitrypsin in transgenic mice revealed by in Situ hybridiza-
tion. Genes Dev 3:16—25, 1989
64. SIFERS RN, CARLSON JA, CLIFT SM, DEMAYO FJ, BULLOCK DW,
Woo SL: Tissue specific expression of the human alpha-1-antitrypsin
gene in transgenic mice. NucI Acid Res 15:1459—1475, 1987
65. SHEN RF, CLIP-IT SM, DEMAYO JL, SIFERS RN, FINEGOLD MJ, Woo
SL: Tissue-specific regulation of human alpha 1-antitrypsin gene
expression in transgenic mice. DNA 8:101—108, 1989
66. SEPULVEDA AR, FINEGOLD MJ, SMITH B, SLAGLE BL, DEMAYO JL,
SHEN RF, Woo SL, BUTEL JS: Development of a transgenic mouse
system for the analysis of stages in liver carcinogenesis using tissue-
specific expression of SV4O large T-antigen controlled by regulatory
elements of the human alpha-1-antitrypsin gene. Cancer Res 49:6108—
6117, 1989
67. DUBIN RA, WAWROUSEK EF, PIATIGORSKY J: Expression of the
murine alpha B-crystallin gene is not restricted to the lens. Mol Cell
Biol 9:1083—1091, 1989
68. SMITH JD, PLUMP AS, HAYEK T, WALSH A, BRESLOW JL: Accumula-
tion of human apolipoprotein E in the plasma of transgenic mice. J
Biol Chem 265:14709—14712, 1990
69. SIMONET WS, BUCAY N, LAUER SJ, WIRAK DO, STEVENS ME,
WEISGRABER KH, PITAS RE, TAYLOR JM: In the absence of a
downstream element, the apolipoprotein E gene is expressed at high
levels in kidneys of transgenic mice. J Biol Chem 265:10809—10812,
1990
70. PASTAN I, WILLINGHAM MC, GOT1TESMAN M: Molecular manipula-
tions of the multidrug transporter: A new role for transgenic mice.
FASEB J 5:2523—2528, 1991
71. KRESS C, VOGELS R, DE GW, BONNEROT C, MEIJLINK F, NIC0L.As iF,
DESCHAMPS J: Hox-2.3 upstream sequences mediate lacZ expression
in intermediate mesoderm derivatives of transgenic mice. Develop-
ment 109:775—786, 1990
72. NEZNANOV N, THOREY IS, CECENA G, OSHIMA RG: Transcriptional
insulation of the human keratin 18 gene in transgenic mice. Mol Cell
Biol 13:2214—2223, 1993
73. MONTEIRO MJ, HOFFMAN PN, GEARHART JD, CLEVELAND DW:
Expression of NF-L in both neuronal and nonneuronal cells of
transgenic mice: Increased neurofilament density in axons without
affecting caliber. J Cell Biol 111:1543—1157, 1990
74. DALRYMPLE SA, BEEMON KL: BK virus T antigens induce kidney
carcinomas and thymoproliferative disorders in transgenic mice. J
Virol 64:1182—1191, 1990
75. SCHMIDT EV, CHRISTOPH G, ZELLER R, LEDER P: The cytomegalo-
virus enhancer: A pan-active control element in transgenic mice. Mol
Cell Biol 10:4406—4411, 1990
76. AKMAL M, EL GI-loR GA, BURK RD: DNase I hypersensitive site maps
to the HBV enhancer. Virology 172:478—488, 1989
77. Aiu K, MIYAZAKJ J, Hmto 0, TOMITA N, CHISAKA 0, MATSUBARA
K, YAMAMURA K: Expression and replication of hepatitis B virus
genome in transgenic mice. Proc NatlAcad Sci USA 86:207—211, 1989
78. BURR RD, DELOIA JA, EL AWADY MK, GEARHART JD: Tissue
preferential expression of the hepatitis B virus (HBV) surface antigen
gene in two lines of HBV transgenic mice. J Virol 62:649—654, 1988
79. FARZA H, HADCHOUEL M, SCorro J, TIOLLAIS P, BABINET C, PouR-
CEL C: Replication and gene expression of hepatitis B virus in a
transgenic mouse that contains the complete viral genome. J Vi rot
62:4144—4152, 1988
80. YAMAMURA K, AR.&Iu K, HIN0 0, TOMITA N, MIYAZAKI J, MATSUB-
ARA K: HBV production in transgenic mice. Gastroenterol Jpn 2:49—
52, 1990
81. SCHAFFNER DL, BARRIOS R, MASSEY C, BANEZ El, Ou CN, RAJAGO-
PALAN S, AGUILAR CE, LEBOVITZ RM, OVERBEEK PA, LIEBERMAN
MW: Targeting of the rasT24 oncogene to the proximal convoluted
tubules in transgenic mice results in hyperplasia and polycystic
kidneys. Am J Pathol 142:1051—1060, 1993
82. ALEXANDER JM, HSU D, PENCHUK L, HEINRICH G: Cell-specific and
developmental regulation of a nerve growth factor-human growth
hormone fusion gene in transgenic mice. Neuron 3:133—139, 1989
83. TRONIK D, DREYFUS M, BABINET C, ROUGEON F: Regulated expres-
sion of the Ren-2 gene in transgenic mice derived from parental
strains carrying only the Ren-1 gene. EMBO J 6:983—987, 1987
84. SIGMUND CD, JONES CA, FABIAN JR, MULLINS JJ, GROSS KW: Tissue
and cell specific expression of a renin promoter-reporter gene con-
struct in transgenic mice. Biochem Biophys Res Commun 170:344—350,
1990
85. SIGMUND CD, JONES CA, JACOB HJ, INGELFINGER J, KIM U, GAMBLE
D, DzAU VJ, GROSS KW: Pathophysiology of vascular smooth muscle
in renin promoter-T-antigen transgenic mice. Am J Physiol 1991
86. STOKLIN E, BOITERI F, GRONER B: An activated allele of the c-erb-2
oncogene impairs kidney and lung function and causes early death of
transgenic. J Cell Biol 122:199—208, 1993
87. FUKAMIZU A, SEO MS, HATAE T, YOKOYAMA M, NOMURA T, KATSUKI
M, MURAKAMI K: Tissue-specific expression of the human renin gene
in transgenic mice. Biochem Biophys Res Commun 165:826—832, 1989
